Literature DB >> 16513316

Development and validation of a dissolution test for rabeprazole sodium in coated tablets.

Cassia V Garcia1, Clesio S Paim, Martin Steppe, Elfrides E S Schapoval.   

Abstract

The aim of this work is to develop and validate a dissolution test for rabeprazole sodium coated tablets using a reverse-phase liquid chromatographic method. After test sink conditions, dissolution medium and stability of the drug, the best conditions were: paddle at 75 rotations per minute (rpm) stirring speed, HCl 0.1 M and borate buffer pH 9.0 as dissolution medium for acidic and basic steps, respectively, volume of 900 ml for both. The quantitation method was also adapted and validated. Less than 10% of the label amount was released in the acid step, while more than 95% was achieved over 30 min in the basic one. The dissolution profile for tablets was considered satisfactory. The dissolution test developed was adequate for its purpose and could be applied for quality control of rabeprazole tablets, since there is no official monograph.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513316     DOI: 10.1016/j.jpba.2006.01.050

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  In vitro release profile of anti-ulcer drug rabeprazole from biocompatible psyllium-PVA hydrogels.

Authors:  Baljit Singh; Harinder Lal; Lok Pal; Vikrant Sharma
Journal:  J Mater Sci Mater Med       Date:  2012-02-25       Impact factor: 3.896

2.  Stability-indicating HPLC-DAD methods for determination of two binary mixtures: Rabeprazole sodium-mosapride citrate and rabeprazole sodium-itopride hydrochloride.

Authors:  Hamed M El-Fatatry; Mokhtar M Mabrouk; Ismail I Hewala; Ehab H Emam
Journal:  J Pharm Anal       Date:  2013-09-23

3.  Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.

Authors:  Yinhe Tan; Xiaoqing Si; Lulu Zhong; Xin Feng; Xinmin Yang; Min Huang; Chuanbin Wu
Journal:  Drug Dev Ind Pharm       Date:  2016-04-11       Impact factor: 3.225

4.  Selection of a Water-Soluble Salt Form of a Preclinical Candidate, IIIM-290: Multiwell-Plate Salt Screening and Characterization.

Authors:  Vikas Kumar; Sandip B Bharate; Ram A Vishwakarma; Sonali S Bharate
Journal:  ACS Omega       Date:  2018-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.